表紙
市場調查報告書
商品編碼
1027139

坐骨神經痛的全球市場:各疾病類型、各類藥物、各給藥途徑、各銷售管道、各地區 - 市場規模,佔有率,展望,機會分析(2021年∼2028年)

Sciatica Market, by Disease Type, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 237 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球坐骨神經痛市場規模,由於坐骨神經痛的盛行率增加,預計促進成長。

本報告提供全球坐骨神經痛市場的相關調查,市場動態,市場分析,市場佔有率,企業分析等全面性資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告的說明
    • 市場定義及範圍
  • 摘要整理
    • 市場概述:各疾病類型
    • 市場概述:各類藥物
    • 市場概述:各給藥途徑
    • 市場概述:各銷售管道
    • 市場概述:各地區
    • 市場機會藍圖

第3章 全球坐骨神經痛市場考察

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的開發
  • 合併,收購,協定
  • 開發平台分析
  • 法規方案
  • 償付方案
  • 市場趨勢
  • 最近的產品銷售/核准
  • 治療流程
  • PEST分析
  • 坐骨神經痛的流行病學為基礎的模式

第4章 全球坐骨神經痛市場 - COVID-19的影響

  • 經濟影響
  • 流行病學
  • 醫藥品開發及臨床實驗的影響

第5章 全球坐骨神經痛市場:各疾病類型(2017年∼2028年)(百萬美元)

  • 簡介
  • 急性坐骨神經痛
  • 慢性坐骨神經痛
  • 其他

第6章 全球坐骨神經痛市場:各類藥物(2017年∼2028年)(百萬美元)

  • 簡介
  • 非類固醇消炎劑
  • 口服類固醇
  • 抗痙攣藥
  • 三環抗憂鬱藥物
  • 類鴉片物質止痛藥
  • 其他

第7章 全球坐骨神經痛市場:各給藥途徑(2017年∼2028年)(百萬美元)

  • 簡介
  • 口服
  • 注射

第8章 全球坐骨神經痛市場:各銷售管道(2017年∼2028年)(百萬美元)

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第9章 全球坐骨神經痛市場:各地區(2017年∼2028年)(百萬美元)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭概述

企業簡介

  • Sorrento Therapeutics, Inc.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Teva Pharmaceutical Industries Ltd.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Aurobindo Pharma Ltd.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Zydus Cadila
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Glenmark Pharmaceuticals Ltd.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Amneal Pharmaceuticals LLC
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Jubilant Life Sciences Ltd.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Hikma Pharmaceuticals PLC
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Mylan N.V.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Horizon Therapeutics Plc
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Sun Pharmaceutical Industries Ltd.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Alkem Labs
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • SCILEX Pharmaceuticals, Inc
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Seikagaku Corporation
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Kolon Life Science, Inc.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • Teijin Limited
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略
  • SpineThera, Inc.
    • 企業亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 策略

第11章 Section

目錄
Product Code: CMI4607

Sciatica refers to pain that radiates along the path of the sciatic nerve, which passes from lower back through hips to buttocks and down each leg. Typically, sciatica affects only one side of the body. This is often a chronic condition that is managed through the use of analgesics to control the pain and non-steroidal anti-inflammatory drugs (NSAIDS) to decrease inflammation. Sciatica is differentiated depending upon the severity of the pain faced by individuals such as acute sciatica, chronic sciatica, and others.

Acute sciatic is known as recent onset of pain in sciatic nerve for duration of four to eight weeks and pain can be self-managed by individuals through pain medications. In chronic sciatica, symptoms include persistent sciatic nerve pain, which lasts over eight weeks in individuals. There are two other types of sciatica which include alternating sciatica and bilateral sciatica. Alternating sciatica is a condition in which the sciatic nerve pain affects in both the legs alternately and thus may lead to degenerative problems in the sacroiliac joint. Bilateral sciatica is a condition in which the sciatic nerve pain occurs in both the legs together, this type of sciatic is very rare and may occur due to degenerative changes in the vertebrae and/or the disc at several spinal levels.

Market Dynamics

Increasing prevalence of sciatica is anticipated to drive the growth of global sciatica market over the forecast period. For instance, according to the article published in the Spine Health in December 2019, sciatica is common condition with a lifetime incidence varying from 10% to 40% of the population in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global sciatica market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sciatica market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global sciatica market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sciatica market

Detailed Segmentation:

  • Global Sciatica Market, By Disease Type:
    • Acute Sciatica
    • Chronic Sciatica
    • Others
  • Global Sciatica Market, By Drug Class:
    • Nonsteroidal Anti-Inflammatory Drugs
    • Oral Steroids
    • Anticonvulsant Agents
    • Tricyclic Antidepressants
    • Opioid Analgesics
    • Others
  • Global Sciatica Market, By Route of Administration:
    • Oral
    • Injectable
  • Global Sciatica Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Sciatica Market, By Region:
    • North America
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Disease Type
      • Acute Sciatica
      • Chronic Sciatica
      • Others
      • By Drug Class
      • Nonsteroidal Anti-Inflammatory Drugs
      • Oral Steroids
      • Anticonvulsant Agents
      • Tricyclic Antidepressants
      • Opioid Analgesics
      • Others
      • By Route of Administration
      • Oral
      • Injectable
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Sorrento Therapeutics, Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Aurobindo Pharma Ltd.
    • Zydus Cadila
    • Glenmark Pharmaceuticals Ltd.
    • Amneal Pharmaceuticals LLC
    • Jubilant Life Sciences Ltd.
    • Hikma Pharmaceuticals PLC.
    • Mylan N.V.
    • Horizon Therapeutics Plc.
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Labs
    • SCILEX Pharmaceuticals, Inc.
    • Seikagaku Corporation
    • Kolon Life Science, Inc.
    • Teijin Limited
    • SpineThera, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Disease Type
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
    • Market Opportunity Map

3. Global Sciatica Market Insights

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Merger, Acquisition & Agreements
  • Pipeline Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • Market Trends
  • Recent Product Launch/Approvals
  • Treatment Algorithm
  • PEST Analysis
  • Epidemiology Based Model for Sciatica

4. Global Sciatica Market-Impact of COVID-19

  • Economic Impact
  • Epidemiology
  • Impact on Drug Development and Clinical Trials

5. Global Sciatica Market, By Disease Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Acute Sciatica
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Chronic Sciatica
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

6. Global Sciatica Market, By Drug Class, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Nonsteroidal Anti-Inflammatory Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Oral Steroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Anticonvulsant Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Tricyclic Antidepressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Opioid Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Sciatica Market, By Route of Administration, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

8. Global Sciatica Market, By Distribution Channel, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

9. Global Sciatica Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Region/Country, 2017-2028, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Snapshot

Company Profiles

    • Sorrento Therapeutics, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Aurobindo Pharma Ltd.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Zydus Cadila
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Glenmark Pharmaceuticals Ltd.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Amneal Pharmaceuticals LLC
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Jubilant Life Sciences Ltd.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Hikma Pharmaceuticals PLC
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Mylan N.V.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Horizon Therapeutics Plc
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Alkem Labs
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • SCILEX Pharmaceuticals, Inc
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Seikagaku Corporation
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Kolon Life Science, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Teijin Limited
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • SpineThera, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies

11. Section

  • Research Methodology
  • About us